Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

New methods to test hair growth treatments have been developed.

Cannabidiol shows promise as an effective treatment for acne.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Liposomes could improve how skin care products work but are costly and not very stable.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Melatonin may help treat PCOS symptoms in rats.